OPTINOSE, INC. Financial and Nonfinancial Liabilities, Fair Value Disclosure
OPTINOSE, INC. had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $15.66 million as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:LiabilitiesFairValueDisclosure · last filed 2025-05-14
- 2025-03-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $15.66M.
- 2024-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $5.10M.
- 2024-09-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $8.50M.
- 2024-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $15.40M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2025-03-31 | $15.66M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $5.10M 10-Q · filed 2025-05-14 |
| 2024-09-30 | $8.50M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $15.40M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $18.50M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $17.20M 10-K · filed 2025-03-26 |
| 2023-09-30 | $14.30M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $11.10M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $22.00M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $21.49M 10-K · filed 2024-03-07 |